市场调查报告书
商品编码
1541054
2024-2032 年按产品、应用、技术(延时显微镜、光漂白后的萤光恢復、萤光共振能量转移、高内涵筛选等)和地区分類的活细胞成像市场报告Live Cell Imaging Market Report by Product, Application, Technology (Time-Lapse Microscopy, Fluorescence Recovery after Photobleaching, Fluorescence Resonance Energy Transfer, High Content Screening, and Others), and Region 2024-2032 |
2023年全球活细胞成像IMARC Group规模达23亿美元。由于研究蛋白质的操作效率而导致的需求不断上升、开发新药的医学研究不断创新以及由于采用久坐的生活方式而导致的各种慢性病的患病率不断上升,这些都是推动市场的一些关键因素。
活细胞成像是指检查生长培养基中随时间变化的动态活细胞。它包含在显微镜载物台上培养细胞的详细方案和技术,并保持恆定的焦平面以即时追踪细胞过程。它依靠相差显微镜和明场来照亮细胞培养物并检查各种细胞器,例如质体、粒线体、中心体、内质网和核醣体。它受到成像方式、介质、温度、湿度、pH、渗透压和光子剂量的影响,这些对于维持细胞健康至关重要。活细胞成像还可以监测细胞融合事件,透过使用光漂白后萤光恢復 (FRAP) 确定分子的迁移率,并测量各种修改,例如一段时间内凝结物的生长或老化。它透过端点检测中经常错过的瞬态事件的可视化提供重要的细胞资料,并揭示最佳时间点。它通常用于检查受精过程、细胞发育、细胞信号传导过程和细胞分化。此外,由于活细胞成像可提供有关细胞培养物的准确资讯,因此被世界各地的生物学家、药理学家和毒理学家所利用。
目前,由于活细胞成像在研究蛋白质和各种分子相互作用方面的操作效率,对活细胞成像的需求不断增加,这是对市场产生积极影响的主要因素之一。除此之外,医学研究领域的创新数量不断增加,以开发新的药物和疗法来治疗个人的各种危及生命的疾病。再加上久坐的生活方式导致各种慢性病的盛行率不断上升,这提供了良好的市场前景。此外,越来越多地利用高内涵筛选(HCS)来提高药物开发过程的时间和成本效益,并降低毒性,正在推动市场的成长。除此之外,各国管理机构为改善医疗基础设施和开发先进的外科手术以为患者提供有效治疗而进行的投资不断增加,也促进了市场的成长。此外,研究实验室越来越多地使用活细胞成像来维持细胞活力,这也促进了市场的成长。此外,主要市场参与者正在开发活细胞成像技术,在相机技术、灵敏度和像素密度方面具有各种增强功能。
The global live cell imaging market size reached US$ 2.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.6 Billion by 2032, exhibiting a growth rate (CAGR) of 7.7% during 2024-2032. The escalating demand due to its operational efficiency in studying proteins, rising innovations made in medical research to develop novel drugs, and the growing prevalence of various chronic diseases due to the adoption of sedentary lifestyles represent some of the key factors driving the market.
Live cell imaging refers to the examination of dynamic living cells in their growth medium that change over time. It comprises detailed protocols and techniques to culture cells on the microscope stage and maintains a constant focal plane to follow cellular processes in real time. It relies on phase contrast microscopy and brightfield to illuminate the cell culture and examine various cell organelles, such as plastids, mitochondria, centrosomes, endoplasmic reticulum, and ribosomes. It is influenced by imaging modality, media, temperature, humidity, pH, osmolarity, and photon dose, which are essential for maintaining cellular health. Live cell imaging also allows monitoring of cell fusion events, determining the mobility of molecules by using fluorescence recovery after photobleaching (FRAP) and measuring various modifications, such as growth or aging of condensate over a period. It provides essential cellular data through the visualization of transient events that are often missed in endpoint assays and revealing optimal time points. It is often utilized to examine the fertilization process, cellular development, cell signaling process, and cell differentiation. Furthermore, as live cell imaging provides accurate information on cell cultures, it is utilized by biologists, pharmacologists, and toxicologists around the world.
At present, the escalating demand for live cell imaging due to its operational efficiency in studying proteins and a wide variety of molecular interactions represents one of the primary factors influencing the market positively. Besides this, there is a rise in the number of innovations made in medical research to develop novel drugs and therapies to treat various life-threatening conditions in individuals. This, coupled with the growing prevalence of various chronic diseases due to the adoption of sedentary lifestyles, is offering a favorable market outlook. In addition, the increasing utilization of high-content screening (HCS) to make drug development processes time and cost-efficient and reduce toxicity is propelling the growth of the market. Apart from this, the rising number of investments made by governing agencies of various countries to improve healthcare infrastructure and develop advanced surgical procedures to provide effective treatment to patients is contributing to the growth of the market. Additionally, the increasing employment of live cell imaging in research laboratories to maintain cell viability is bolstering the market growth. Furthermore, key market players are developing live cell imaging techniques with various enhanced features in camera technology, sensitivity, and pixel density.
IMARC Group provides an analysis of the key trends in each sub-segment of the global live cell imaging market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, application and technology.
Equipment
Consumable
Software
The report has provided a detailed breakup and analysis of the live cell imaging market based on the product. This includes equipment, consumable, and software. According to the report, equipment represented the largest segment.
Cell Biology
Developmental Biology
Stem Cell and Drug Discovery
Others
A detailed breakup and analysis of the live cell imaging market based on the application has also been provided in the report. This includes cell biology, developmental biology, stem cell and drug discovery, and others. According to the report, cell biology accounted for the largest market share.
Time-Lapse Microscopy
Fluorescence Recovery after Photobleaching (FRAP)
Fluorescence Resonance Energy Transfer (FRET)
High Content Screening (HCS)
Others
A detailed breakup and analysis of the live cell imaging market based on the technology has also been provided in the report. This includes time lapse microscopy, fluorescence recovery after photobleaching (FRAP), fluorescence resonance energy transfer (FRET), high content screening (HCS), and others. According to the report, fluorescence recovery after photobleaching (FRAP) accounted for the largest market share.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (the United Kingdom, Germany, France, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for live cell imaging. Some of the factors driving the North America live cell imaging market included rising investments made by governing agencies, increasing occurrence of cancer among the masses, the growing initiatives in drug discovery, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global live cell imaging market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have also been provided. Some of the companies covered include Becton Dickinson and Company (BD), Carl Zeiss AG, Leica Microsystems (Danaher Corporation), Merck KGaA, Nikon Instruments Inc., Olympus Corporation, PerkinElmer Inc., Thermo Fisher Scientific Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.